Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.33 |
| ▸ | CCKBR | P32239 | 1/20 | 0.33 |
| ▸ | MC4R | P32245 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20501825 | 0.73 | CSF1R (0.37) | CSF1RALDH1A1HSD17B10NPC1RAB9A | |
| SCHEMBL22188458 | 0.71 | LMNA (0.39) | CSF1RALDH1A1HSD17B10NPC1RAB9A | |
| SCHEMBL3448381 | 0.69 | CTSA (0.47) | CTSA | |
| SCHEMBL20475050 | 0.69 | MAPT (0.33) | ALDH1A1LMNATP53HTTMAPT | |
| SCHEMBL3101768 | 0.66 | PTPRA (0.37) | CSF1RALDH1A1HSD17B10NPC1RAB9A | |
| SCHEMBL10349460 | 0.66 | TSHR (0.42) | ALDH1A1SMN1; SMN2CTSAKDM4E | |
| SCHEMBL279917 | 0.64 | FFAR1 (0.51) | ALDH1A1CYP2C19SMN1; SMN2CYP26A1 | |
| SCHEMBL1262878 | 0.64 | NPSR1 (0.50) | ALDH1A1LMNATP53CYP1A2CYP2C19 | |
| SCHEMBL8771313 | 0.63 | POLB (0.57) | RAB9ALMNACYP1A2HTTSMN1; SMN2 | |
| SCHEMBL30556756 | 0.63 | AKR1B1 (0.45) | ALDH1A1LMNACYP1A2HTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7192931-B2 | Treatment of demyelinating diseases | NEUREN PHARMACEUTICALS LTD. (NZ) | 2007-03-20 | — | — | US | claimed |
| WO-2025030033-A1 | APILIMOD COMPOSITIONS AND METHODS OF USE | ORPHAI THERAPEUTICS INC. (US) | 2025-02-06 | — | — | WO | disclosed |
| CN-116930351-A | Method for measuring related substances of key starting materials of pirenzepine by HPLC | 上海现代制药股份有限公司 | 2023-10-24 | — | — | CN | disclosed |
| EP-4188382-A1 | ADMINISTRATION OF MODULATORS OF 5-HT AND/OR AMPA RECEPTORS FOR TREATING NEUROLOGICAL CONDITIONS | The Royal Institution for the Advancement of Learning / McGill University (CA) | 2023-06-07 | — | — | EP | disclosed |
| WO-2022023813-A1 | ADMINISTRATION OF MODULATORS OF 5-HT AND/OR AMPA RECEPTORS FOR TREATING NEUROLOGICAL CONDITIONS | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2022-02-03 | — | — | WO | disclosed |
| US-20170312308-A1 | XENON AND/OR ARGON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERS | THE MCLEAN HOSPITAL CORPORATION (US) | 2017-11-02 | — | — | US | disclosed |
| US-9737562-B2 | Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders | THE MCLEAN HOSPITAL CORPORATION (US) | 2017-08-22 | — | — | US | disclosed |
| US-20150306136-A1 | XENON AND/OR ARGON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERS | THE MCLEAN HOSPITAL CORPORATION (US) | 2015-10-29 | — | — | US | disclosed |